Gland Pharma Limited Cash Flow Quality Index
Gland Pharma Limited cash flow quality index. Gland Pharma Limited (GLAND) has a Cash Flow Quality Index of 1.49x as of September 2025. Operating cash flow of Rs5.93 Billion exceeds net income of Rs3.99 Billion, indicating high earnings quality where cash backs reported profits. See financial flexibility index of Gland Pharma Limited to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Gland Pharma Limited (2017–2026)
Cash flow quality index of Gland Pharma Limited from 2017 to 2026. Historical Cash Flow Quality Index for Gland Pharma Limited across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore GLAND operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Gland Pharma Limited Cash Flow Quality Index by Year (2017–2026)
Gland Pharma Limited cash flow quality index by year from 2017 to 2026. Year-by-year earnings quality comparison for Gland Pharma Limited. For the full cash flow conversion analysis, see GLAND cash flow metrics.
| Year | Quality Index | Operating CF (INR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2026 | 1.20x | Rs12.31 Billion | Rs10.27 Billion | ▼ -8.5% |
| 2025 | 1.31x | Rs9.15 Billion | Rs6.99 Billion | ▲ +1.5% |
| 2024 | 1.29x | Rs9.97 Billion | Rs7.72 Billion | ▲ +273.9% |
| 2023 | 0.35x | Rs3.64 Billion | Rs10.55 Billion | ▼ -29.4% |
| 2022 | 0.49x | Rs7.91 Billion | Rs16.19 Billion | ▲ +7.8% |
| 2021 | 0.45x | Rs6.05 Billion | Rs13.35 Billion | ▼ -35.8% |
| 2020 | 0.71x | Rs7.01 Billion | Rs9.93 Billion | ▲ +161.5% |
| 2019 | 0.27x | Rs1.85 Billion | Rs6.86 Billion | ▼ -33.0% |
| 2018 | 0.40x | Rs2.02 Billion | Rs5.01 Billion | ▼ -65.0% |
| 2017 | 1.15x | Rs4.76 Billion | Rs4.14 Billion | — |